The recall covers more than 7,000 bottles of duloxtine, sold as Cymbalta, due to the presence of nitrosamines.

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

The FDA recently authorized two drugs, MIPLYFFA (arimoclomol) and AQNEURSA (levacetylleucine) that are supposed to help stop the progression of the rare disease, Niemann-Pick Disease type C.

Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own ...

Over 7,000 bottles of the antidepressant medication duloxetine, sold under the brand name Cymbalta, have been recalled, the ...

The FDA recalled thousands of bottles of antidepressants after finding high levels of potentially cancer-causing chemicals. Here's what to look for.

Oral cefixime is a third-generation cephalosporin that has a similar antibacterial spectrum to ceftriaxone. Cefixime is ...

Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by ...